Trial intelligence / Profile preview

Mpepu: Cotrimoxazole and Breastfeeding Duration in HIV-Exposed Infants

NCT01229761Phase 2Completed

Sponsor
Harvard T.H. Chan School of Public Health
Start
May 2011
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of trimethoprim + sulfamethoxazole in human immunodeficiency virus infection (HIV), sponsored by Harvard T.H. Chan School of Public Health. Started May 2011; status: completed.

02

Drugs

trimethoprim + sulfamethoxazole
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01229761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01229761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call